Water Tower Research Publishes Initiation of Coverage Report on InMed Pharmaceuticals, Inc. Titled “A Unique Developer of Rare Cannabinoid-Based Therapies”

Press Release Apr 26, 2023

April 26, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on InMed Pharmaceuticals, Inc. (NASDAQ: INM) titled, “A Unique Developer of Rare Cannabinoid-Based Therapies”. The report can be accessed here. Vancouver-headquartered and […]

Cognetivity Neurosciences to provide ground-breaking monitoring capability for cognitively impaired patients in UK primary care

Press Release Nov 17, 2020

Integrated Cognitive Assessment’s speed, ease of administration and lack of learning effect enable monitoring of NHS patients with mild cognitive impairment Vancouver, British Columbia, November 17, 2020 – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; OTCQB: CGNSF; FWB: […]

Tag: Alzheimer’s

Water Tower Research Publishes Initiation of Coverage Report on InMed Pharmaceuticals, Inc. Titled “A Unique Developer of Rare Cannabinoid-Based Therapies”

Cognetivity Neurosciences to provide ground-breaking monitoring capability for cognitively impaired patients in UK primary care

Cookies & Privacy